Aurisco(SH:605116) Shang Hai Zheng Quan Bao·2025-09-12 20:26Core Points - The announcement details the listing of 6,606,000 restricted shares of Aorite Pharmaceutical Co., Ltd. on September 22, 2025, following the expiration of a 60-month lock-up period [2][3][12] - The total share capital of the company after the initial public offering (IPO) is 406,195,234 shares, with 1.63% of this being the newly listed restricted shares [4][6][8] Group 1: Listing Details - The type of stock being listed is the initial public offering (IPO) shares, with a total of 6,606,000 shares available for trading [2] - The listing date for the restricted shares is set for September 22, 2025 [3][13] Group 2: Share Capital Changes - The company initially issued 41,000,000 shares during its IPO, resulting in a total share capital of 401,000,000 shares, which includes 41,000,000 unrestricted shares and 360,000,000 restricted shares [4][5] - The total share capital increased to 406,195,234 shares due to the issuance of 5,195,000 restricted shares under the 2022 incentive plan and the conversion of 234 shares from convertible bonds [6][8] Group 3: Lock-up Commitments - The shareholder, Tiantai Boren Investment Management Partnership, has committed to a lock-up period of 60 months for the shares prior to the IPO and has adhered to this commitment [9][11] - The shareholder's commitment includes conditions for share reduction and penalties for non-compliance, ensuring transparency and accountability [9]